Defiance Daily Target 2X Long HIMS ETF (HIMZ) Holdings $15.55 -0.77 (-4.72%) As of 03:03 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock Top 8 HIMZ HoldingsRankCompanyCurrent PriceWeightShares Held1US DOLLARSN/A87.03%121,590,6862HIMS & HERS HEALTH INC COM MAREXN/A61.86%1,712,8003HIMS & HERS HEALTH INC SWAP CLEARSTREETN/A55.14%1,526,6674HIMS & HERS HEALTH INC SWAP BMON/A51.83%1,435,0005First American Government Obligations FundN/A4.53%6,334,7316DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A3.37%4,713,3637HIMSHims & Hers Health$46.09-2.2%2.88%79,8248Cash OffsetN/A-166.64%232,825,873 Geographic ExposureUnited States15.9%Currency ExposureUSD103.8%Sector ExposureHealth Care6.8%Industry ExposureHealth Care Providers & Services6.8%SubIndustry ExposureHealth Care Services6.8%Coupon Exposure4-64.7%Maturity Exposure5-104.7% Related Companies and Tools Related Companies Defiance Daily Target 2X Long IONQ ETF Holdings Tradr 2X Long APP Daily ETF Holdings Direxion Daily NFLX Bull 2X Shares Holdings T-Rex 2X Inverse Tesla Daily Target ETF Holdings Direxion Daily AVGO Bull 2X Shares Holdings Defiance Daily Target 2X Long AVGO ETF Holdings Direxion Daily TSM Bull 2X Shares Holdings GraniteShares Yieldboost TSLA ETF Holdings GraniteShares 2x Short TSLA Daily ETF Holdings Direxion Daily TSLA Bear 1X Shares Holdings This page (NASDAQ:HIMZ) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Daily Target 2X Long HIMS ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Defiance Daily Target 2X Long HIMS ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access